Comment by hermanzegerman

6 hours ago

Your own link says

Survival rates for ESRD are higher in Europe than the U.S. This could be explained by the inferiority of national standards of care, a higher prevalence of patients with diabetes and differences in practice patterns.

Let's look at actual journals

For those with ESKD onset from 2004 to 2008, unadjusted 5-year survival of all patients with ESKD (treated with dialysis or transplantation) was 41% in the USA, 48% in Europe, and 60% in Japan, despite patients being 2–3 years older on average in Europe and Japan than in the USA, and Japan having very few transplant patients.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6...

The US had a much higher KRT incidence, prevalence, and mortality compared to Europe, and despite a higher kidney transplantation rate, a lower proportion of prevalent patients with a functioning graft.

https://pubmed.ncbi.nlm.nih.gov/38439701/